View Older Stories View More Recent Stories

Nov 4, 2025 09:34AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
Nov 4, 2025 08:06AM Hims and Hers (HIMS) PT Lowered to $48 at Jefferies, 'want to see proof points of consumer traction'
Nov 4, 2025 06:22AM Hims and Hers (HIMS) PT Raised to $46 at Leerink Partners
Nov 4, 2025 06:06AM KeyBanc: 'Hims and Hers (HIMS) Setting the Stage for Future Growth'
Nov 4, 2025 05:13AM Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'
Nov 4, 2025 05:10AM Hims and Hers (HIMS) PT Raised to $32 at BofA Securities
Nov 4, 2025 04:35AM BTIG Hims and Hers (HIMS): 'MAHA is being Implemented through HIMS with Proactive Health'
Nov 4, 2025 03:20AM Canaccord Genuity Reiterates Buy Rating on Hims and Hers (HIMS)
Nov 3, 2025 04:41PM After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina
Nov 3, 2025 04:10PM Hims & Hers in talks with Novo Nordisk to offer Wegovy treatments
Nov 3, 2025 04:09PM Hims & Hers Health, Inc. (HIMS) Misses Q3 EPS by 4c, Offers Guidance
Nov 3, 2025 10:17AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put into quarter results
Oct 31, 2025 10:29AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put into quarter results
Oct 31, 2025 04:26AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put into quarter results
Oct 28, 2025 09:03AM TD Cowen on Hims and Hers (HIMS): 'Decelerating Trends; Lack of Upside Likely'
Oct 21, 2025 04:35AM KeyBanc Starts Hims and Hers (HIMS) at Sector Weight
Oct 20, 2025 11:42AM Hims & Hers CEO Dudum comments on Grail investment
Oct 15, 2025 10:07AM BofA: 'We maintain our Underperform rating on HIMS due to growing competition, but view this morning’s news positively'
Oct 15, 2025 09:03AM Hims & Hers launches menopause treatment services
Oct 15, 2025 08:51AM Hims & Hers to Offer Treatments for Menopause, Perimenopause - DJ
Oct 10, 2025 06:14AM BofA Negative on Hims and Hers (HIMS): 'Lowering 4Q sales and full year below the guidance range'
Oct 9, 2025 09:05AM Hims & Hers releases customer survey data on telehealth care quality
Oct 2, 2025 04:23PM Hims & Hers CEO Dudum announces COO change, appointing Mike Chi
Oct 2, 2025 04:07PM Hims & Hers names Mike Chi as new COO as Nader Kabbani transitions
Oct 1, 2025 06:24AM BofA Reiterating Negative View on Hims and Hers (HIMS): '3Q beat less likely, order growth under more pressure'
Sep 24, 2025 08:34AM Survey shows 1/3 of GLP-1 users are lower-income
Sep 22, 2025 12:33PM Walmart (WMT) Adds Home Delivery for Ozempic, Other Refrigerated Drugs - Bloomberg
Sep 19, 2025 03:45PM GoodRx (GDRX) Lower on Report Trump Officials Weigh Website To Help Shop For Cheaper Drugs
Sep 16, 2025 01:24PM Hims & Hers Health, Inc. (HIMS) CEO Andrew Dudum: around 100 FDA letters went out last week to companies across the industry, we got one
Sep 16, 2025 10:46AM FDA issues warning letter to HIMS over semaglutide marketing claims
Sep 15, 2025 02:37PM CMS Launches Landmark $50 Billion Rural Health Transformation Program
Sep 15, 2025 08:17AM BofA Securities on Hims and Hers (HIMS): 'Dr. Makary’s op-ed in the New York Times is a negative for HIMS'
Sep 15, 2025 07:22AM Hims & Hers shares drop after FDA chief flags ad violations
Sep 12, 2025 05:39AM Canaccord Genuity Positive on Hims and Hers (HIMS): 'we see several paths to FY30 targets'
Sep 12, 2025 05:23AM BTIG Remains Positive Hims and Hers (HIMS)
Sep 4, 2025 08:52AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS) 'given near-term competitive pressures in the core business'
Sep 4, 2025 05:13AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $28
Aug 18, 2025 05:17AM Hims and Hers (HIMS) PT Lowered to $37 at Truist Securities
Aug 15, 2025 08:01AM Hims and Hers (HIMS) July orders fall further - BofA
Aug 15, 2025 06:30AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put
Aug 14, 2025 06:06PM Hims House podcast shares statement from Hims & Hers regarding Bloomberg report
Aug 14, 2025 04:43PM After-hours movers: UnitedHealth, Applied Materials, Intel, Hims & Hers Health
Aug 14, 2025 04:11PM Hims & Hers Health, Inc. (HIMS) Probed By US FTC Over Cancellation Practices - Bloomberg
Aug 8, 2025 05:40AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.6 calls to 1 put with a focus on August 55 calls
Aug 7, 2025 09:29AM HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman
Aug 6, 2025 09:55AM Popular stocks volume: HIMS INTC SNAP OPEN UNH SMCI RIVN HOOD COIN UBER MSTR PFE
Aug 5, 2025 02:04PM Novo Nordisk files 14 new lawsuits over compounded semaglutide drugs
Aug 5, 2025 02:02PM Hims & Hers Health, Inc. (HIMS) on Watch; Novo Nordisk (NVO) Expands Legal Action to Protect US Patients From Non-FDA-approved Compounded 'Semaglutide'
Aug 5, 2025 10:52AM Popular stocks volume: HIMS HOOD PFE SMCI SOFI COIN
Aug 5, 2025 09:32AM BTIG Reiterates Buy Rating on Hims and Hers (HIMS), PT $85
View More Recent Stories View Older Stories